PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Shows a significant decrease in neuronal injury [PMID: 31206893]
Extracts showed strong antibacterial activity against Staphylococcus epidermidis and Bacillus cereus [PMID: 38338335]; essential oils inhibited various Gram-positive and Gram-negative bacteria, except Pseudomonas aeruginosa [PMID: 11677025, 19735193].
Chloroform (CHCl3) extracts showed significant antiprotozoal activity against L. donovani [PMID: 22224291]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31206893 (2019) — Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited. · BioFactors (Oxford, England)
- 2.PMID: 25146764 (2014) — Essential-oil diversity of Salvia tomentosa Mill. in Greece. · Chemistry & biodiversity
- 3.PMID: 40836519 (2023) — Phytochemical Profile, Antioxidant and Antimicrobial Potency of Aerial Parts of Salvia Tomentosa Miller. · Acta chimica Slovenica
- 4.PMID: 38338335 (2024) — The Effect of Salvia tomentosa Miller Extracts, Rich in Rosmarinic, Salvianolic and Lithospermic Acids, on Bacteria Causing Opportunistic Infections. · Molecules (Basel, Switzerland)
- 5.PMID: 28480423 (2017) — GEOMETRIC, VOLUMETRIC, COLOUR AND FRICTIONAL PROPERTIES OF SELECTED SALVIA SPECIES OF TURKEY.